New Article in Cytotherapy

Our new paper on marketing of unproven stem cell interventions and the role of medical societies in patient advocacy and education is published in Cytotherapy.

This work was in collaboration with Daniel J. Weiss, Professor of Medicine, University of Vermont College of Medicine; Leigh Turner, Associate Professor, Center for Bioethics, University of Minnesota; and Aaron D. Levine, Associate Professor, School of Public Policy, Georgia Institute of Technology.

Lab Members Next Steps

Congratulations to Keri Dame and Matt Lawton on their next career steps! Keri is now an ORISE Fellow in the Division of Applied Regulatory Science of the FDA and Matt is a graduate student at Boston University’s Program in Biomedical Sciences.

Stem Cell Working Group writes patient-centered piece on unproven stem cell therapies

Screen Shot 2017-06-16 at 7.16.25 PM.png

April 1st, 2017

Dr. Ikonomou and other members of the American Thoracic Society Stem Cell Working Group wrote an AJRCCM patient-centric Public Health information piece on unproven “stem cell” interventions for lung disease. Thanks to the ATS, the COPD Foundation, the Asian Pacific Society of Respirology, the Pulmonary Hypertension Association of Canada and the Malaysian Thoracic Society for featuring this piece on their websites.